×

Please Remove Adblock
Adverts are the main source of Revenue for DoveMed. Please remove adblock to help us create the best medical content found on the Internet.

FDA And The Brazilian Health Regulatory Agency (ANVISA)

Last updated April 15, 2016

Approved by: Krish Tangella MD, MBA, FCAP

To support this collaboration and other activities of mutual interest, FDA and ANVISA will also rely on the attached, established statement of cooperation between the parties.


Joint Statement 
 

FDA—ANVISA
Statement of Continued Cooperation Between FDA and ANVISA 
Zika Virus Disease

April 11, 2016


This statement expresses the intent of the United States Food and Drug Administration (FDA) and the Brazilian Health Regulatory Agency (ANVISA) to offer mutual support and to collaborate to address the public health emergency presented by the Zika virus disease outbreak in the Americas. To execute this goal, FDA and ANVISA will further enhance cooperative efforts with robust scientific and technical exchanges, as well as timely and effective communication. In this spirit of cooperation, openness, and mutual support, FDA and ANVISA are committed to advancing our public health missions and mitigating the negative public health impact of Zika virus disease. To support this collaboration and other activities of mutual interest, FDA and ANVISA will also rely on the attached, established statement of cooperation between the parties.

Footnote

1. Referred to as the National Health Surveillance Agency of Brazil (ANVISA) in earlier documents.


Cooperative Arrangement to Enhance Activities of Mutual Interest (Issued: November 26, 2012)

Confidentiality Commitment Documents (Issued: September 24, 2010)

FDA
ANVISA

  

The above post is reprinted from materials provided by U.S. Food and Drug AdministrationNote: Materials may be edited for content and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Reviewed and Approved by a member of the DoveMed Editorial Board
First uploaded: April 15, 2016
Last updated: April 15, 2016